Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Trend
Above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
50.00%
↑ 339% above average
Average (39q)
11.40%
Historical baseline
Range
High:1500.00%
Low:-566.67%
CAGR
+1.8%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 50.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 1500.00% |
| Q4 2024 | -90.00% |
| Q3 2024 | 900.00% |
| Q2 2024 | 113.40% |
| Q1 2024 | 60.74% |
| Q4 2023 | -101.91% |
| Q3 2023 | -17.63% |
| Q2 2023 | 55.56% |
| Q1 2023 | 0.00% |
| Q4 2022 | -183.91% |
| Q3 2022 | 74.64% |
| Q2 2022 | 7.41% |
| Q1 2022 | -8.00% |
| Q4 2021 | 35.90% |
| Q3 2021 | -5.41% |
| Q2 2021 | 7.50% |
| Q1 2021 | -566.67% |
| Q4 2020 | 82.35% |
| Q3 2020 | -41.67% |
| Q2 2020 | -4.35% |
| Q1 2020 | 70.51% |
| Q4 2019 | -271.43% |
| Q3 2019 | -23.53% |
| Q2 2019 | -21.43% |
| Q1 2019 | 17.65% |
| Q4 2018 | 19.05% |
| Q3 2018 | -10.53% |
| Q2 2018 | -5.56% |
| Q1 2018 | -350.00% |
| Q4 2017 | 75.00% |
| Q3 2017 | -453.63% |
| Q2 2017 | 96.86% |
| Q1 2017 | -513.33% |
| Q4 2016 | 28.57% |
| Q3 2016 | -110.00% |
| Q2 2016 | 23.08% |
| Q1 2016 | -8.33% |
| Q4 2015 | 25.00% |